Evidence map›Paper›PMID 39458731›Full record

ArticlePolymers2024

Continuous Material Deposition on Filaments in Fused Deposition Modeling.

Guy Naim, Shlomo Magdassi, Daniel Mandler

Abstract read
In one paragraph

Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Guy NaimInstitute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
Shlomo MagdassiInstitute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.ORCID 0000-0002-6794-0553
Daniel MandlerInstitute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.ORCID 0000-0003-2490-1084

Funding

Hebrew University of Jerusalem n/a
6 · The paper itself

Abstract

A novel approach, i.e., Continuous Material Deposition on Filaments (CMDF), for the incorporation of active materials within 3D-printed structures is presented. It is based on passing a filament through a solution in which the active material is dissolved together with the polymer from which the filament is made. This enables the fabrication of a variety of functional 3D-printed objects by fused deposition modeling (FDM) using commercial filaments without post-treatment processes. This generic approach has been demonstrated in objects using three different types of materials, Rhodamine B, ZnO nanoparticles (NPs), and Ciprofloxacin (Cip). The functionality of these objects is demonstrated through strong antibacterial activity in ZnO NPs and the controlled release of the antibiotic Cip. CMDF does not alter the mechanical properties of FDM-printed structures, can be applied with any type of FDM printer, and is, therefore, expected to have applications in a wide variety of fields.

Indexed as

3D printingciprofloxacincoatingcontinuous material deposition on filaments (CMDF)filament treatmentfused deposition modelingPLApreprintingrhodamine BZnO

Identifiers

PMID39458731
PMCPMC11511081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.